SQI Diagnostics Inc.  

(Public, CVE:SQD)   Watch this stock  
Find more results for cve: sqd
0.370
+0.030 (8.82%)
Dec 19 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.37 - 0.37
52 week 0.25 - 0.70
Open 0.37
Vol / Avg. 15,000.00/10,253.00
Mkt cap 20.84M
P/E     -
Div/yield     -
EPS -0.11
Shares 56.34M
Beta 1.33
Inst. own     -
Dec 17, 2014
Q4 2014 SQI Diagnostics Inc Earnings Call
Dec 17, 2014
Q4 2014 SQI Diagnostics Inc Earnings Release
  

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin -2307.46% -4588.23%
Operating margin -2317.91% -4605.04%
EBITD margin - -3968.07%
Return on average assets -116.58% -116.21%
Return on average equity -126.09% -128.32%
Employees 33 -
CDP Score - -

Address

36 Meteor Dr
ETOBICOKE, ON M9W 1A4
Canada
+1-416-6749500 (Phone)
+1-416-6749300 (Fax)

Website links

Description

SQI Diagnostics Inc. (SQI) is a Canada-based life sciences company. The Company develops and commercializes technologies and products for microarray diagnostics. The Company provides clinical, reference, academic and diagnostic development laboratories in the In Vitro Diagnostics (IVD) segment and diagnostic companies, contract research organizations (CRO), and pharmaceutical and vaccine developers, which requires diagnostic processing equipment and consumable tests in the Diagnostic Tools and Services segment. The Company�s products include SQiDworks, SQiDlite, SQiD-X, IgX PLEX Rheumatoid Arthritis, IgX PLEX Celiac, Ig_PLEX Celiac DGP Panel, Ig_PLEX Vasculitis Panel, 8 plex Cytokine RUO, Ig_PLEX Rheumatoid Arthritis, Ig_PLEX Lupus Panel, Ig_PLEX TNF, Ig_PLEX IBD and Ig_PLEX APS.

Officers and directors

Andrew Morris President, Chief Executive Officer, Director
Peter D. Winkley Chairman of the Board
Allan Pronovost Ph.D. Director
Age: 55
Claude Ricks Director
Paul J. Mountain Independent Director
Saied Nadjafi Independent Director
Eric N. Schneider Independent Director